TIGO

What TIGO does

TIGO GmbH is a German private limited company headquartered in Wiesbaden that develops innovative medicinal products, nutritional supplements, and medical devices. The company operates three integrated product lines: research and marketing of pharmaceutical products, development of nutritional supplements, and development of medical devices. Beyond product development, TIGO GmbH offers consultancy and business coaching services spanning healthcare, logistics, and design. The firm is registered as a GmbH at Amtsgericht Wiesbaden under HRB 22810 with VAT ID DE 253791418 and conducts business from Johann-Sebastian-Bach-Straße 27 in Wiesbaden.

The company is founded and managed by two M.D. partners, Dr. Hans-Günther Grigoleit and Dr. Patricia Grigoleit. Dr. Hans-Günther Grigoleit has held leading positions in clinical research, marketing, and management within globally operating pharmaceutical companies and is the author of 82 scientific papers and co-editor of 6 books; he has served as a senior advisor to the EU and its institutions for more than a decade. Dr. Patricia Grigoleit brings over 25 years of pharmaceutical industry experience spanning API and finished dosage form development, marketing, sales, and general management, supplemented by appointments as Senior Advisor/Specialist at the European Bank for Reconstruction and Development and as a Business Coach for SMEs funded by the European Commission.

Operating with 11 to 50 employees, TIGO GmbH is structured as a boutique pharmaceutical development and consulting firm rather than a software or digital platform, with no mobile application, public API, or disclosed digital infrastructure in the available source material. There are no disclosed AI capabilities, data assets, or recurring product KPIs, and revenue, customer data, and pricing are not publicly disclosed. Income is generated through product development engagements in regulated healthcare categories (medicinal products, supplements, medical devices) alongside adjacent advisory services in healthcare, logistics, and design.

Name

TIGO

Legal name

TIGO GmbH

Website

https://tigo-gamma.eu

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

TIGO GmbH, a Wiesbaden-based German private company, develops innovative medicinal products, nutritional supplements, and medical devices. Run by two M.D. founders with deep pharma industry expertise, the firm also offers healthcare, logistics, and design consultancy and business coaching.

Ownership category

akta.pro rank

Headquarters

HQ city

Wiesbaden

HQ country

Germany

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

1. Mobile telecommunications services: Revenue from mobile voice, data, and messaging services provided to consumers and enterprises across Latin American markets
2. Fixed broadband subscriptions: Revenue from fixed broadband internet subscriptions, showing significant growth in markets like Honduras
3. Network infrastructure services: Revenue-generating network services including 5G connectivity in key cities

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

TIGO GmbH develops innovative medicinal products, nutritional supplements, and medical devices, and applies innovation in logistics and design. The company additionally provides consultancy and business coaching in the above areas of expertise, including services such as clinical research, regulatory affairs, medical marketing, pharma-IT consultancy, and pharmaceutical marketing & sales, addressing clients ranging from pharmaceutical industry players to small and medium-sized enterprises.

Product overview

TIGO GmbH is a German pharmaceutical and healthcare company that operates as a single integrated business focused on product development and consulting services. The company develops three core product lines: innovative medicinal products (including clinical research and pharmaceutical marketing), nutritional supplements, and medical devices. These are complemented by consultancy and business coaching services in healthcare, logistics, and design. The portfolio is unified under the TIGO brand with no modular architecture—the company functions as a development and consulting firm rather than a software platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Innovative Medicinal Products Development of innovative medicinal products as a core area of expertise, targeting pharmaceutical industry clients seeking novel therapeutic product development supported by TIGO's medical and consulting know-how.
• Nutritional Supplements Development of nutritional supplements offered as part of TIGO GmbH's healthcare product portfolio, developed for clients in the pharmaceutical and nutraceutical sectors.
• Medical Devices Development of medical devices as a core product-development offering, alongside medicinal products and nutritional supplements, for healthcare and pharmaceutical clients.
• Logistics and Design Consultancy Consultancy and business coaching in innovations in logistics and design, offered to clients as part of TIGO GmbH's broader advisory practice alongside its pharmaceutical product development work.
• Healthcare and Pharma Consulting Services Broader consultancy engagement spanning clinical research, regulatory affairs, medical marketing, pharma-IT consultancy, and pharmaceutical marketing & sales, sold to pharmaceutical and healthcare organizations seeking integrated advisory support.
• SME Business Coaching Business coaching for Small and Medium-sized Enterprises, funded by the European Commission and delivered through Managing Partner Patricia Grigoleit, providing executive-level coaching and innovation advisory to SME clients across Europe.

Quantifiable outcome

• Over 250,000 Salvadorans to benefit from network upgrades
• +1 more outcomes

Named customers2 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• GSMA Open GatewaycoreStrategic or Co-development Partner · 3 February 2026TIGO in Colombia joined GSMA Open Gateway initiative with two digital solutions to combat online fraud, representing strategic participation in industry-wide digital security efforts.

Scale indicators6 records

Recent moves3 records

Expansion highlights1 record

Broad incumbents

• B. Braun: A major German medical devices and pharmaceuticals company. Comparable to TIGO GmbH on the medical device product line, though at vastly greater scale and product breadth.
• PharmaLex (now part of Cencora): A global pharmaceutical consulting and regulatory services provider. Comparable to TIGO GmbH's pharma consultancy offering, especially given the founders' regulatory advisory experience, though operating at enterprise scale.
• Aenova Group: A larger German pharmaceutical contract manufacturer offering development, production, and packaging of solid dosage forms and APIs. Comparable to TIGO GmbH in pharmaceutical product development, though operating at much greater scale and breadth.
• Stern-Wywiol Gruppe (incl. SternEnzym, SternVitamin): A German group of companies specializing in food and nutritional supplement ingredients (vitamins, enzymes, systems). Comparable to TIGO GmbH's nutritional supplements line given the German-based ingredient and supplement focus.
• MEDA Pharma (now Mylan/Viatris): A large specialty pharmaceutical company historically focused on prescription and OTC medicines. Comparable to TIGO GmbH in medicinal product development and marketing orientation, though at global enterprise scale.

Direct peers

• Dr. Wolff Group: A German family-owned pharmaceutical and cosmetics company developing medicinal products and consumer health brands. Comparable to TIGO GmbH as a mid-sized German player combining medicinal product development with consumer health.
• Vetter Pharma: A German contract development and manufacturing organization (CDMO) specializing in aseptic filling of medicinal products and clinical supply. Comparable to TIGO GmbH as a Germany-based pharma development services provider serving the medicinal product value chain.
• Hermes Arzneimittel: A German mid-sized pharmaceutical company focused on development and marketing of medicinal products, including OTC and supplements. Comparable to TIGO GmbH in business model combining product development with pharmaceutical marketing.

Others

• Designit (a Wipro company): A global design and innovation consultancy. Comparable to TIGO GmbH's design consultancy service line, providing a reference point for the non-regulated portion of TIGO's offering.

Emerging players

• Salvia Bioelectronics: An early-stage European medical device developer. Comparable to TIGO GmbH as a smaller European medical device development entity, though focused on neurostimulation rather than a broad device portfolio.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks5 records

Key highlights4 records

Customer concentration

• LinkedInlinkedin.com/company/tigo-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TIGO